{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:02Z","timestamp":1794019982792,"version":"4.8.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo","award":["13\/08028-1"],"award-info":[{"award-number":["13\/08028-1"]}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo","award":["13\/08028-1"],"award-info":[{"award-number":["13\/08028-1"]}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo","award":["13\/08028-1"],"award-info":[{"award-number":["13\/08028-1"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["303712\/2016-3, 466651\/2014-7"],"award-info":[{"award-number":["303712\/2016-3, 466651\/2014-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"INCT-FAPESP","award":["14\/50931"],"award-info":[{"award-number":["14\/50931"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Ment Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function variants in the dystrophin gene, a well-known cause of muscular dystrophies, have emerged as a mutational risk mechanism for autism spectrum disorder (ASD), which in turn is a highly prevalent (~\u20091%) genetically heterogeneous neurodevelopmental disorder. Although the association of intellectual disability with the dystrophinopathies Duchenne (DMD) and Becker muscular dystrophy (BMD) has been long established, their association with ASD is more recent, and the dystrophin genotype-ASD phenotype correlation is unclear. We therefore present a review of the literature focused on the ASD prevalence among dystrophinopathies, the relevance of the dystrophin isoforms, and most particularly the relevance of the genetic background to the etiology of ASD in these patients. Four families with ASD-DMD\/BMD patients are also reported here for the first time. These include a single ASD individual, ASD-discordant and ASD-concordant monozygotic twins, and non-identical ASD triplets. Notably, two unrelated individuals, which were first ascertained because of the ASD phenotype at ages 15 and 5\u00a0years respectively, present rare dystrophin variants still poorly characterized, suggesting that some dystrophin variants may compromise the brain more prominently. Whole exome sequencing in these ASD-DMD\/BMD individuals together with the literature suggest, although based on preliminary data, a complex and heterogeneous genetic architecture underlying ASD in dystrophinopathies, that include rare variants of large and medium effect. The need for the establishment of a consortia for genomic investigation of ASD-DMD\/BMD patients, which may shed light on the genetic architecture of ASD, is discussed.<\/jats:p>","DOI":"10.1007\/s44192-022-00008-z","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T01:02:22Z","timestamp":1648083742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dystrophin genetic variants and autism"],"prefix":"10.1007","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-3008","authenticated-orcid":false,"given":"Maria Rita","family":"Passos-Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-8462","authenticated-orcid":false,"given":"Claudia Ismania Samogy","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3970-8025","authenticated-orcid":false,"given":"Mayana","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"M-C Lai","year":"2014","unstructured":"Lai M-C, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383:896\u2013910. https:\/\/doi.org\/10.1016\/S0140-6736(13)61539-1.","journal-title":"Lancet"},{"key":"8_CR2","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 2013."},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","volume":"392","author":"C Lord","year":"2018","unstructured":"Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(18)31129-2.","journal-title":"Lancet"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3992","volume":"16","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015;16:551\u201363. https:\/\/doi.org\/10.1038\/nrn3992.","journal-title":"Nat Rev Neurosci"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.gde.2012.03.002","volume":"22","author":"B Devlin","year":"2012","unstructured":"Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012;22:229\u201337. https:\/\/doi.org\/10.1016\/j.gde.2012.03.002.","journal-title":"Curr Opin Genet Dev"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.2147\/NDT.S65455","volume":"12","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Wilson CE, Robertson DM, Ecker C, Daly EM, Hammond N, et al. Autism spectrum disorder in adults: diagnosis, management, and health services development. Neuropsychiatr Dis Treat. 2016;12:1669\u201386. https:\/\/doi.org\/10.2147\/NDT.S65455.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pcn.12128","volume":"68","author":"E Shishido","year":"2014","unstructured":"Shishido E, Aleksic B, Ozaki N. Copy-number variation in the pathogenesis of autism spectrum disorder. Psychiatry Clin Neurosci. 2014;68:85\u201395. https:\/\/doi.org\/10.1111\/pcn.12128.","journal-title":"Psychiatry Clin Neurosci"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamapsychiatry.2019.1411","volume":"76","author":"D Bai","year":"2019","unstructured":"Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiat. 2019;76:1035\u201343. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1411.","journal-title":"JAMA Psychiat"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.cell.2019.07.037","volume":"178","author":"LM Iakoucheva","year":"2019","unstructured":"Iakoucheva LM, Muotri AR, Sebat J. Getting to the cores of autism. Cell. 2019;178:1287\u201398. https:\/\/doi.org\/10.1016\/j.cell.2019.07.037.","journal-title":"Cell"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41386-020-0768-y","volume":"46","author":"VB Searles Quick","year":"2021","unstructured":"Searles Quick VB, Wang B, State MW. Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders. Neuropsychopharmacology. 2021;46:55\u201369. https:\/\/doi.org\/10.1038\/s41386-020-0768-y.","journal-title":"Neuropsychopharmacology"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","volume":"180","author":"FK Satterstrom","year":"2020","unstructured":"Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An J-Y, et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020;180:568-584.e23. https:\/\/doi.org\/10.1016\/j.cell.2019.12.036.","journal-title":"Cell"},{"key":"8_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.15.460398","author":"T Wang","year":"2021","unstructured":"Wang T, Kim C, Bakken TE, Gillentine MA, Henning B, Mao Y, et al. Integrated gene analyses of de novo mutations from 46,612 trios with autism and developmental disorders. BioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.09.15.460398.","journal-title":"BioRxiv"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nn.4524","volume":"20","author":"RK Yuen","year":"2017","unstructured":"Yuen RK, Merico D, Bookman M, Howe LJ, Thiruvahindrapuram B, Patel RV, et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci. 2017;20:602\u201311. https:\/\/doi.org\/10.1038\/nn.4524.","journal-title":"Nat Neurosci"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ajhg.2013.07.024","volume":"93","author":"N Krumm","year":"2013","unstructured":"Krumm N, O\u2019Roak BJ, Karakoc E, Mohajeri K, Nelson B, Vives L, et al. Transmission disequilibrium of small CNVs in simplex autism. Am J Hum Genet. 2013;93:595\u2013606. https:\/\/doi.org\/10.1016\/j.ajhg.2013.07.024.","journal-title":"Am J Hum Genet"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cell.2017.08.047","volume":"171","author":"TN Turner","year":"2017","unstructured":"Turner TN, Coe BP, Dickel DE, Hoekzema K, Nelson BJ, Zody MC, et al. Genomic patterns of de novo mutation in simplex autism. Cell. 2017;171:710\u201322. https:\/\/doi.org\/10.1016\/j.cell.2017.08.047.","journal-title":"Cell"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ng.3303","volume":"47","author":"N Krumm","year":"2015","unstructured":"Krumm N, Turner TN, Baker C, Vives L, Mohajeri K, Witherspoon K, et al. Excess of rare, inherited truncating mutations in autism. Nat Genet. 2015;47:582\u20138. https:\/\/doi.org\/10.1038\/ng.3303.","journal-title":"Nat Genet"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41576-020-0231-2","volume":"21","author":"CP Schaaf","year":"2020","unstructured":"Schaaf CP, Betancur C, Yuen RKC, Parr JR, Skuse DH, Gallagher L, et al. A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat Rev Genet. 2020;21:367\u201376. https:\/\/doi.org\/10.1038\/s41576-020-0231-2.","journal-title":"Nat Rev Genet"},{"key":"8_CR18","volume-title":"GeneReviews\u00ae","author":"K Phelan","year":"1993","unstructured":"Phelan K, Rogers RC, et al. Phelan-McDermid syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 1993."},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1866-1955-6-39","volume":"6","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2014;6:39. https:\/\/doi.org\/10.1186\/1866-1955-6-39.","journal-title":"J Neurodev Disord"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-019-9273-1","volume":"11","author":"CI Samogy-Costa","year":"2019","unstructured":"Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype\u2013phenotype correlation and identification of an atypical case. J Neurodev Disord. 2019;11:13. https:\/\/doi.org\/10.1186\/s11689-019-9273-1.","journal-title":"J Neurodev Disord"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41398-018-0339-8","volume":"9","author":"M Niarchou","year":"2019","unstructured":"Niarchou M, Chawner SJ, Doherty JL, Maillard AM, Jacquemont S, Chung WK, et al. Psychiatric disorders in children with 16p11.2 deletion and duplication. Transl Psychiatry. 2019;9:8. https:\/\/doi.org\/10.1038\/s41398-018-0339-8.","journal-title":"Transl Psychiatry"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41436-018-0266-3","volume":"21","author":"L Pizzo","year":"2019","unstructured":"Pizzo L, Jensen M, Polyak A, Rosenfeld JA, Mannik K, Krishnan A, et al. Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants. Genet Med. 2019;21:816\u201325. https:\/\/doi.org\/10.1038\/s41436-018-0266-3.","journal-title":"Genet Med"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fncel.2019.00385","volume":"13","author":"L Rylaarsdam","year":"2019","unstructured":"Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Front Cell Neurosci. 2019;13:385. https:\/\/doi.org\/10.3389\/fncel.2019.00385.","journal-title":"Front Cell Neurosci"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/s41436-019-0629-4","volume":"21","author":"Y Du","year":"2019","unstructured":"Du Y, Li Z, Liu Z, Zhang N, Wang R, Li F, et al. Correction: nonrandom occurrence of multiple de novo coding variants in a proband indicates the existence of an oligogenic model in autism. Genet Med. 2019;21:2662\u20133. https:\/\/doi.org\/10.1038\/s41436-019-0629-4.","journal-title":"Genet Med"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1516767","volume":"376","author":"JE Posey","year":"2017","unstructured":"Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376:21\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1516767.","journal-title":"N Engl J Med"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/gim.2018.33","volume":"20","author":"E Karaca","year":"2018","unstructured":"Karaca E, Posey JE, Coban Akdemir Z, Pehlivan D, Harel T, Jhangiani SN, et al. Phenotypic expansion illuminates multilocus pathogenic variation. Genet Med. 2018;20:1528\u201337. https:\/\/doi.org\/10.1038\/gim.2018.33.","journal-title":"Genet Med"},{"key":"8_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004580","volume":"10","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, et al. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet. 2014;10: e1004580. https:\/\/doi.org\/10.1371\/journal.pgen.1004580.","journal-title":"PLoS Genet"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1093\/hmg\/ddr243","volume":"20","author":"CP Schaaf","year":"2011","unstructured":"Schaaf CP, Sabo A, Sakai Y, Crosby J, Muzny D, Hawes A, et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet. 2011;20:3366\u201375. https:\/\/doi.org\/10.1093\/hmg\/ddr243.","journal-title":"Hum Mol Genet"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.conb.2012.04.007","volume":"22","author":"BP Coe","year":"2012","unstructured":"Coe BP, Girirajan S, Eichler EE. A genetic model for neurodevelopmental disease. Curr Opin Neurobiol. 2012;22:829\u201336. https:\/\/doi.org\/10.1016\/j.conb.2012.04.007.","journal-title":"Curr Opin Neurobiol"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466:368\u201372. https:\/\/doi.org\/10.1038\/nature09146.","journal-title":"Nature"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng.534","volume":"42","author":"S Girirajan","year":"2010","unstructured":"Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet. 2010;42:203\u20139. https:\/\/doi.org\/10.1038\/ng.534.","journal-title":"Nat Genet"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/humu.23561","volume":"39","author":"RT Wang","year":"2018","unstructured":"Wang RT, Barthelemy F, Martin AS, Douine ED, Eskin A, Lucas A, et al. DMD genotype correlations from the Duchenne registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype. Hum Mutat. 2018;39:1193\u2013202. https:\/\/doi.org\/10.1002\/humu.23561.","journal-title":"Hum Mutat"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2223\/JPED.2148","volume":"88","author":"F Nardes","year":"2012","unstructured":"Nardes F, Ara\u00fajo APQC, Ribeiro MG. Mental retardation in Duchenne muscular dystrophy. J Pediatr (Rio J). 2012;88:6\u201316. https:\/\/doi.org\/10.2223\/JPED.2148.","journal-title":"J Pediatr (Rio J)"},{"key":"8_CR34","first-page":"480","volume":"33","author":"T Kumagai","year":"2001","unstructured":"Kumagai T, Miura K, Ohki T, Matsumoto A, Miyazaki S, Nakamura M, et al. Central nervous system involvements in Duchenne\/Becker muscular dystrophy. No To Hattatsu. 2001;33:480\u20136.","journal-title":"No To Hattatsu"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2003;2:731\u201340. https:\/\/doi.org\/10.1016\/s1474-4422(03)00585-4.","journal-title":"Lancet Neurol"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0165-0173(99)00090-9","volume":"32","author":"MF Mehler","year":"2000","unstructured":"Mehler MF. Brain dystrophin, neurogenetics and mental retardation. Brain Res Rev. 2000;32:277\u2013307. https:\/\/doi.org\/10.1016\/S0165-0173(99)00090-9.","journal-title":"Brain Res Rev"},{"key":"8_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-021-01933-4","author":"M Mohamadian","year":"2021","unstructured":"Mohamadian M, Rastegar M, Pasamanesh N, Ghadiri A, Ghandil P, Naseri M. Clinical and molecular spectrum of muscular dystrophies (MDs) with intellectual disability (ID): a comprehensive overview. J Mol Neurosci. 2021. https:\/\/doi.org\/10.1007\/s12031-021-01933-4.","journal-title":"J Mol Neurosci"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/s0012162205000496","volume":"47","author":"SM Cotton","year":"2005","unstructured":"Cotton SM, Voudouris NJ, Greenwood KM. Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis. Dev Med Child Neurol. 2005;47:257\u201365. https:\/\/doi.org\/10.1017\/s0012162205000496.","journal-title":"Dev Med Child Neurol"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.nmd.2017.11.018","volume":"28","author":"R Battini","year":"2018","unstructured":"Battini R, Chieffo D, Bulgheroni S, Piccini G, Pecini C, Lucibello S, et al. Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: the role of executive functions. Neuromuscul Disord. 2018;28:122\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.018.","journal-title":"Neuromuscul Disord"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2478\/bjmg-2014-0071","volume":"17","author":"V Milic Rasic","year":"2014","unstructured":"Milic Rasic V, Vojinovic D, Pesovic J, Mijalkovic G, Lukic V, Mladenovic J, et al. Intellectual ability in the duchenne muscular dystrophy and dystrophin gene mutation location. Balkan J Med Genet. 2014;17:25\u201335. https:\/\/doi.org\/10.2478\/bjmg-2014-0071.","journal-title":"Balkan J Med Genet"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/0883073815570154","volume":"30","author":"R Banihani","year":"2015","unstructured":"Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, et al. Cognitive and neurobehavioral profile in boys with duchenne muscular dystrophy. J Child Neurol. 2015;30:1472\u201382. https:\/\/doi.org\/10.1177\/0883073815570154.","journal-title":"J Child Neurol"},{"key":"8_CR42","doi-asserted-by":"publisher","DOI":"10.4081\/mi.2012.e5","volume":"4","author":"TD Filippo","year":"2012","unstructured":"Filippo TD, Parisi L, Roccella M. Psychological aspects in children affected by duchenne de boulogne muscular dystrophy. Ment Illn. 2012;4: e5. https:\/\/doi.org\/10.4081\/mi.2012.e5.","journal-title":"Ment Illn"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/adc.40.211.296","volume":"40","author":"V Dubowitz","year":"1965","unstructured":"Dubowitz V. Intellectual impairment in muscular dystrophy. Arch Dis Child. 1965;40:296\u2013301. https:\/\/doi.org\/10.1136\/adc.40.211.296.","journal-title":"Arch Dis Child"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.braindev.2017.11.004","volume":"40","author":"M Mori-Yoshimura","year":"2018","unstructured":"Mori-Yoshimura M, Mizuno Y, Yoshida S, Minami N, Yonemoto N, Takeuchi F, et al. Social involvement issues in patients with Becker muscular dystrophy: a questionnaire survey of subjects from a patient registry. Brain Dev. 2018;40:268\u201377. https:\/\/doi.org\/10.1016\/j.braindev.2017.11.004.","journal-title":"Brain Dev"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0883073807307975","volume":"23","author":"HK Young","year":"2008","unstructured":"Young HK, Barton BA, Waisbren S, Portales Dale L, Ryan MM, Webster RI, et al. Cognitive and psychological profile of males with Becker muscular dystrophy. J Child Neurol. 2008;23:155\u201362. https:\/\/doi.org\/10.1177\/0883073807307975.","journal-title":"J Child Neurol"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0883073817701368","volume":"32","author":"R Latimer","year":"2017","unstructured":"Latimer R, Street N, Conway KC, James K, Cunniff C, Oleszek J, et al. Secondary conditions among males with duchenne or becker muscular dystrophy. J Child Neurol. 2017;32:663\u201370. https:\/\/doi.org\/10.1177\/0883073817701368.","journal-title":"J Child Neurol"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10072-018-3341-2","volume":"39","author":"H Fujino","year":"2018","unstructured":"Fujino H, Saito T, Matsumura T, Shibata S, Iwata Y, Fujimura H, et al. Autism spectrum disorders are prevalent among patients with dystrophinopathies. Neurol Sci. 2018;39:1279\u201382. https:\/\/doi.org\/10.1007\/s10072-018-3341-2.","journal-title":"Neurol Sci"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mus.26750","volume":"61","author":"JT Lambert","year":"2020","unstructured":"Lambert JT, Darmahkasih AJ, Horn PS, Rybalsky I, Shellenbarger KC, Tian C, et al. Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy. Muscle Nerve. 2020;61:156\u201362. https:\/\/doi.org\/10.1002\/mus.26750.","journal-title":"Muscle Nerve"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/dmcn.12922","volume":"58","author":"V Ricotti","year":"2016","unstructured":"Ricotti V, Mandy WPL, Scoto M, Pane M, Deconinck N, Messina S, et al. Neurodevelopmental, emotional, and behavioural problems in duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Dev Med Child Neurol. 2016;58:77\u201384. https:\/\/doi.org\/10.1111\/dmcn.12922.","journal-title":"Dev Med Child Neurol"},{"key":"8_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/0883073807309775","volume":"23","author":"JGM Hendriksen","year":"2008","unstructured":"Hendriksen JGM, Vles JSH. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive\u2013compulsive disorder. J Child Neurol. 2008;23:477\u201381. https:\/\/doi.org\/10.1177\/0883073807309775.","journal-title":"J Child Neurol"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nmd.2013.01.011","volume":"23","author":"M Pane","year":"2013","unstructured":"Pane M, Messina S, Bruno C, D\u2019Amico A, Villanova M, Brancalion B, et al. Duchenne muscular dystrophy and epilepsy. Neuromuscul Disord. 2013;23:313\u20135. https:\/\/doi.org\/10.1016\/j.nmd.2013.01.011.","journal-title":"Neuromuscul Disord"},{"key":"8_CR52","doi-asserted-by":"publisher","DOI":"10.14744\/DAJPNS.2019.00052","author":"U \u00f6zer","year":"2019","unstructured":"\u00f6zer U. Psychiatric comorbidities in cases with Duchenne muscular dystrophy: case series. Dusunen Adam. 2019. https:\/\/doi.org\/10.14744\/DAJPNS.2019.00052.","journal-title":"Dusunen Adam"},{"key":"8_CR53","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1007\/s00415-020-09792-6","volume":"267","author":"A Tesei","year":"2020","unstructured":"Tesei A, Nobile M, Colombo P, Civati F, Gandossini S, Mani E, et al. Mental health and coping strategies in families of children and young adults with muscular dystrophies. J Neurol. 2020;267:2054\u201369. https:\/\/doi.org\/10.1007\/s00415-020-09792-6.","journal-title":"J Neurol"},{"key":"8_CR54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24:482\u201391. https:\/\/doi.org\/10.1016\/j.nmd.2014.03.008.","journal-title":"Neuromuscul Disord"},{"key":"8_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen G-JB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34:135\u201344. https:\/\/doi.org\/10.1002\/mus.20586.","journal-title":"Muscle Nerve"},{"key":"8_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7:13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3.","journal-title":"Nat Rev Dis Primers"},{"key":"8_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The TREAT-NMD DMD Global Database: analysis of more than 7000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395\u2013402. https:\/\/doi.org\/10.1002\/humu.22758.","journal-title":"Hum Mutat"},{"key":"8_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135189","volume":"10","author":"J Juan-Mateu","year":"2015","unstructured":"Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, et al. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS ONE. 2015;10: e0135189. https:\/\/doi.org\/10.1371\/journal.pone.0135189.","journal-title":"PLoS ONE"},{"key":"8_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fgene.2020.00131","volume":"11","author":"M Neri","year":"2020","unstructured":"Neri M, Rossi R, Trabanelli C, Mauro A, Selvatici R, Falzarano MS, et al. The genetic landscape of dystrophin mutations in italy: a nationwide study. Front Genet. 2020;11:131. https:\/\/doi.org\/10.3389\/fgene.2020.00131.","journal-title":"Front Genet"},{"key":"8_CR60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/hmg\/2.5.521","volume":"2","author":"JM Tinsley","year":"1993","unstructured":"Tinsley JM, Blake DJ, Davies KE. Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site. Hum Mol Genet. 1993;2:521\u20134. https:\/\/doi.org\/10.1093\/hmg\/2.5.521.","journal-title":"Hum Mol Genet"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12035-012-8233-5","volume":"45","author":"T Tozawa","year":"2012","unstructured":"Tozawa T, Itoh K, Yaoi T, Tando S, Umekage M, Dai H, et al. The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain. Mol Neurobiol. 2012;45:287\u201397. https:\/\/doi.org\/10.1007\/s12035-012-8233-5.","journal-title":"Mol Neurobiol"},{"key":"8_CR62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0014-5793(98)01566-x","volume":"441","author":"PL Howard","year":"1998","unstructured":"Howard PL, Klamut HJ, Ray PN. Identification of a novel actin binding site within the Dp71 dystrophin isoform. FEBS Lett. 1998;441:337\u201341. https:\/\/doi.org\/10.1016\/s0014-5793(98)01566-x.","journal-title":"FEBS Lett"},{"key":"8_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061546","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi T, Niba ETE, Rani AQM, Onishi Y, Koizumi M, Awano H, et al. Detection of dystrophin dp71 in human skeletal muscle using an automated capillary western assay system. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19061546.","journal-title":"Int J Mol Sci"},{"key":"8_CR64","doi-asserted-by":"publisher","first-page":"12575","DOI":"10.1038\/s41598-017-12981-5","volume":"7","author":"N Doorenweerd","year":"2017","unstructured":"Doorenweerd N, Mahfouz A, van Putten M, Kaliyaperumal R, T\u2019 Hoen PAC, Hendriksen JGM, et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci Rep. 2017;7:12575. https:\/\/doi.org\/10.1038\/s41598-017-12981-5.","journal-title":"Sci Rep"},{"key":"8_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24116","author":"J Lange","year":"2021","unstructured":"Lange J, Gillham O, Alkharji R, Eaton S, Ferrari G, Madej M, et al. Dystrophin deficiency affects human astrocyte properties and response to damage. Glia. 2021. https:\/\/doi.org\/10.1002\/glia.24116.","journal-title":"Glia"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002;82:291\u2013329. https:\/\/doi.org\/10.1152\/physrev.00028.2001.","journal-title":"Physiol Rev"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2012.04.004","volume":"35","author":"A Waite","year":"2012","unstructured":"Waite A, Brown SC, Blake DJ. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 2012;35:487\u201396. https:\/\/doi.org\/10.1016\/j.tins.2012.04.004.","journal-title":"Trends Neurosci"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1083\/jcb.147.3.645","volume":"147","author":"DJ Blake","year":"1999","unstructured":"Blake DJ, Hawkes R, Benson MA, Beesley PW. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol. 1999;147:645\u201358. https:\/\/doi.org\/10.1083\/jcb.147.3.645.","journal-title":"J Cell Biol"},{"key":"8_CR69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1155\/S1110724302000347","volume":"2","author":"K Culligan","year":"2002","unstructured":"Culligan K, Ohlendieck K. Diversity of the brain dystrophin-glycoprotein complex. J Biomed Biotechnol. 2002;2:31\u20136. https:\/\/doi.org\/10.1155\/S1110724302000347.","journal-title":"J Biomed Biotechnol"},{"key":"8_CR70","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s00018-005-5461-0","volume":"63","author":"T Haenggi","year":"2006","unstructured":"Haenggi T, Fritschy JM. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci. 2006;63:1614\u201331. https:\/\/doi.org\/10.1007\/s00018-005-5461-0.","journal-title":"Cell Mol Life Sci"},{"key":"8_CR71","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s12035-019-01845-w","volume":"57","author":"M Naidoo","year":"2020","unstructured":"Naidoo M, Anthony K. Dystrophin dp71 and the neuropathophysiology of duchenne muscular dystrophy. Mol Neurobiol. 2020;57:1748\u201367. https:\/\/doi.org\/10.1007\/s12035-019-01845-w.","journal-title":"Mol Neurobiol"},{"key":"8_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12035-011-8218-9","volume":"45","author":"R Tadayoni","year":"2012","unstructured":"Tadayoni R, Rendon A, Soria-Jasso LE, Cisneros B. Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene. Mol Neurobiol. 2012;45:43\u201360. https:\/\/doi.org\/10.1007\/s12035-011-8218-9.","journal-title":"Mol Neurobiol"},{"key":"8_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-009-8089-5","volume":"41","author":"GSK Pilgram","year":"2010","unstructured":"Pilgram GSK, Potikanond S, Baines RA, Fradkin LG, Noordermeer JN. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol. 2010;41:1\u201321. https:\/\/doi.org\/10.1007\/s12035-009-8089-5.","journal-title":"Mol Neurobiol"},{"key":"8_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155134","volume":"133","author":"KA Stephenson","year":"2020","unstructured":"Stephenson KA, Rae MG, O\u2019Malley D. Interleukin-6: A neuro-active cytokine contributing to cognitive impairment in Duchenne muscular dystrophy? Cytokine. 2020;133: 155134. https:\/\/doi.org\/10.1016\/j.cyto.2020.155134.","journal-title":"Cytokine"},{"key":"8_CR75","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1152\/jn.00248.2016","volume":"116","author":"MG Rae","year":"2016","unstructured":"Rae MG, O\u2019Malley D. Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. J Neurophysiol. 2016;116:1304\u201315. https:\/\/doi.org\/10.1152\/jn.00248.2016.","journal-title":"J Neurophysiol"},{"key":"8_CR76","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.neubiorev.2007.09.001","volume":"32","author":"SE Cyrulnik","year":"2008","unstructured":"Cyrulnik SE, Hinton VJ. Duchenne muscular dystrophy: a cerebellar disorder? Neurosci Biobehav Rev. 2008;32:486\u201396. https:\/\/doi.org\/10.1016\/j.neubiorev.2007.09.001.","journal-title":"Neurosci Biobehav Rev"},{"key":"8_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2014.10.004","volume":"110","author":"EJ Cohen","year":"2015","unstructured":"Cohen EJ, Quarta E, Fulgenzi G, Minciacchi D. Acetylcholine, GABA and neuronal networks: a working hypothesis for compensations in the dystrophic brain. Brain Res Bull. 2015;110:1\u201313. https:\/\/doi.org\/10.1016\/j.brainresbull.2014.10.004.","journal-title":"Brain Res Bull"},{"key":"8_CR78","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neubiorev.2015.01.023","volume":"51","author":"RGF Hendriksen","year":"2015","unstructured":"Hendriksen RGF, Hoogland G, Schipper S, Hendriksen JGM, Vles JSH, Aalbers MW. A possible role of dystrophin in neuronal excitability: a review of the current literature. Neurosci Biobehav Rev. 2015;51:255\u201362. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.01.023.","journal-title":"Neurosci Biobehav Rev"},{"key":"8_CR79","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/08830738050200100201","volume":"20","author":"JY Wu","year":"2005","unstructured":"Wu JY, Kuban KCK, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005;20:790\u20135. https:\/\/doi.org\/10.1177\/08830738050200100201.","journal-title":"J Child Neurol"},{"key":"8_CR80","doi-asserted-by":"publisher","unstructured":"Madanelo, L. Avalia\u00e7\u00e3o de caracter\u00edsticas do espectro autista em pacientes com Distrofia Muscular de Duchenne. Disserta\u00e7\u00e3o de Mestrado, Instituto de Psicologia, Universidade de S\u00e3o Paulo, S\u00e3o Paulo. https:\/\/doi.org\/10.11606\/D.47.2019.tde-19122018-102629. Retrieved on 2022-02-18, www.teses.usp.br.","DOI":"10.11606\/D.47.2019.tde-19122018-102629"},{"key":"8_CR81","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejpn.2006.04.004","volume":"10","author":"J Darke","year":"2006","unstructured":"Darke J, Bushby K, Le Couteur A, McConachie H. Survey of behaviour problems in children with neuromuscular diseases. Eur J Paediatr Neurol. 2006;10:129\u201334. https:\/\/doi.org\/10.1016\/j.ejpn.2006.04.004.","journal-title":"Eur J Paediatr Neurol"},{"key":"8_CR82","first-page":"10","volume":"40","author":"A Nakamura","year":"2008","unstructured":"Nakamura A, Miyazaki Y, Kumagai T, Suzuki Y. Miura K [Various central nervous system involvements in dystrophinopathy: clinical and genetic considerations]. No To Hattatsu. 2008;40:10\u20134.","journal-title":"No To Hattatsu"},{"key":"8_CR83","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/09297040802665777","volume":"15","author":"J Donders","year":"2009","unstructured":"Donders J, Taneja C. Neurobehavioral characteristics of children with Duchenne muscular dystrophy. Child Neuropsychol. 2009;15:295\u2013304. https:\/\/doi.org\/10.1080\/09297040802665777.","journal-title":"Child Neuropsychol"},{"key":"8_CR84","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.pediatrneurol.2009.05.011","volume":"41","author":"VJ Hinton","year":"2009","unstructured":"Hinton VJ, Cyrulnik SE, Fee RJ, Batchelder A, Kiefel JM, Goldstein EM, et al. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol. 2009;41:339\u201346. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.05.011.","journal-title":"Pediatr Neurol"},{"key":"8_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0033-1347935","volume":"44","author":"S Elsenbruch","year":"2013","unstructured":"Elsenbruch S, Schmid J, Lutz S, Geers B, Schara U. Self-reported quality of life and depressive symptoms in children, adolescents, and adults with Duchenne muscular dystrophy: a cross-sectional survey study. Neuropediatrics. 2013;44:257\u201364. https:\/\/doi.org\/10.1055\/s-0033-1347935.","journal-title":"Neuropediatrics"},{"key":"8_CR86","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ejpn.2017.02.007","volume":"21","author":"P Colombo","year":"2017","unstructured":"Colombo P, Nobile M, Tesei A, Civati F, Gandossini S, Mani E, et al. Assessing mental health in boys with Duchenne muscular dystrophy: Emotional, behavioural and neurodevelopmental profile in an Italian clinical sample. Eur J Paediatr Neurol. 2017;21:639\u201347. https:\/\/doi.org\/10.1016\/j.ejpn.2017.02.007.","journal-title":"Eur J Paediatr Neurol"},{"key":"8_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/currents.md.4cdeb6970e54034db2bc3dfa54b4d987","author":"M Thangarajh","year":"2018","unstructured":"Thangarajh M, Spurney CF, Gordish-Dressman H, Clemens PR, Hoffman EP, McDonald CM, et al. Neurodevelopmental needs in young boys with Duchenne Muscular Dystrophy (DMD): observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS). PLoS Curr. 2018. https:\/\/doi.org\/10.1371\/currents.md.4cdeb6970e54034db2bc3dfa54b4d987.","journal-title":"PLoS Curr"},{"key":"8_CR88","doi-asserted-by":"publisher","first-page":"e1597","DOI":"10.1212\/WNL.0000000000008363","volume":"93","author":"M Thangarajh","year":"2019","unstructured":"Thangarajh M, Hendriksen J, McDermott MP, Martens W, Hart KA, Griggs RC, et al. Relationships between DMD mutations and neurodevelopment in dystrophinopathy. Neurology. 2019;93:e1597\u2013604. https:\/\/doi.org\/10.1212\/WNL.0000000000008363.","journal-title":"Neurology"},{"key":"8_CR89","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/acn3.50867","volume":"6","author":"M Thangarajh","year":"2019","unstructured":"Thangarajh M, Kaat AJ, Bibat G, Mansour J, Summerton K, Gioia A, et al. The NIH Toolbox for cognitive surveillance in Duchenne muscular dystrophy. Ann Clin Transl Neurol. 2019;6:1696\u2013706. https:\/\/doi.org\/10.1002\/acn3.50867.","journal-title":"Ann Clin Transl Neurol"},{"key":"8_CR90","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jpepsy\/jsz062","volume":"44","author":"DMJ Hellebrekers","year":"2019","unstructured":"Hellebrekers DMJ, Lionarons JM, Faber CG, Klinkenberg S, Vles JSH, Hendriksen JGM. Instruments for the assessment of behavioral and psychosocial functioning in Duchenne and Becker muscular dystrophy; a systematic review of the literature. J Pediatr Psychol. 2019;44:1205\u201323. https:\/\/doi.org\/10.1093\/jpepsy\/jsz062.","journal-title":"J Pediatr Psychol"},{"key":"8_CR91","unstructured":"Data and Statistics on Autism Spectrum Disorder|CDC. 2019. https:\/\/www.cdc.gov\/ncbddd\/autism\/data.html. Accessed 5 Aug 2019."},{"key":"8_CR92","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ejhg.2012.269","volume":"21","author":"S Mercier","year":"2013","unstructured":"Mercier S, Toutain A, Toussaint A, Raynaud M, de Barace C, Marcorelles P, et al. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet. 2013;21:855\u201363. https:\/\/doi.org\/10.1038\/ejhg.2012.269.","journal-title":"Eur J Hum Genet"},{"key":"8_CR93","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1002\/ajmg.a.36728","volume":"164A","author":"L Imbornoni","year":"2014","unstructured":"Imbornoni L, Price ET, Andrews J, Meaney FJ, Ciafaloni E, Cunniff C. Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy. Am J Med Genet A. 2014;164A:2769\u201374. https:\/\/doi.org\/10.1002\/ajmg.a.36728.","journal-title":"Am J Med Genet A"},{"key":"8_CR94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ncn3.12265","volume":"7","author":"M Kaido","year":"2019","unstructured":"Kaido M, Yuasa Y. Female carrier withDMD mutation manifesting only asymptomatic hyper CK emia and psychiatric problems. Neurol Clin Neurosci. 2019;7:129\u201331. https:\/\/doi.org\/10.1111\/ncn3.12265.","journal-title":"Neurol Clin Neurosci"},{"key":"8_CR95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2013.09.036","volume":"336","author":"F Giliberto","year":"2014","unstructured":"Giliberto F, Radic CP, Luce L, Ferreiro V, de Brasi C, Szijan I. Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization. J Neurol Sci. 2014;336:36\u201341. https:\/\/doi.org\/10.1016\/j.jns.2013.09.036.","journal-title":"J Neurol Sci"},{"key":"8_CR96","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mus.27057","volume":"62","author":"H Demirci","year":"2020","unstructured":"Demirci H, Durmus H, Toksoy G, Uslu A, Parman Y, Hanagasi H. Cognition of the mothers of patients with Duchenne muscular dystrophy. Muscle Nerve. 2020;62:710\u20136. https:\/\/doi.org\/10.1002\/mus.27057.","journal-title":"Muscle Nerve"},{"key":"8_CR97","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0960-8966(92)90059-f","volume":"2","author":"SV Hodgson","year":"1992","unstructured":"Hodgson SV, Abbs S, Clark S, Manzur A, Heckmatt JZ, Dubowitz V, et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscul Disord. 1992;2:269\u201376. https:\/\/doi.org\/10.1016\/0960-8966(92)90059-f.","journal-title":"Neuromuscul Disord"},{"key":"8_CR98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1469-8749.1995.tb12000.x","volume":"37","author":"KM Bushby","year":"1995","unstructured":"Bushby KM, Appleton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 1995;37:260\u20139. https:\/\/doi.org\/10.1111\/j.1469-8749.1995.tb12000.x.","journal-title":"Dev Med Child Neurol"},{"key":"8_CR99","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pediatrneurol.2011.08.003","volume":"45","author":"MG D\u2019Angelo","year":"2011","unstructured":"D\u2019Angelo MG, Lorusso ML, Civati F, Comi GP, Magri F, Del Bo R, et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011;45:292\u20139. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2011.08.003.","journal-title":"Pediatr Neurol"},{"key":"8_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/aur.2238","volume":"13","author":"EM da Silva Montenegro","year":"2020","unstructured":"da Silva Montenegro EM, Costa CS, Campos G, Scliar M, de Almeida TF, Zachi EC, et al. Meta-analyses support previous and novel autism candidate genes: outcomes of an unexplored Brazilian cohort. Autism Res. 2020;13:199\u2013206. https:\/\/doi.org\/10.1002\/aur.2238.","journal-title":"Autism Res"},{"key":"8_CR101","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cge.14072","volume":"101","author":"CIS Costa","year":"2022","unstructured":"Costa CIS, da Silva Montenegro EM, Zarrei M, de S\u00e1 ME, Silva IMW, de Oliveira SM, et al. Copy number variations in a Brazilian cohort with autism spectrum disorders highlight the contribution of cell adhesion genes. Clin Genet. 2022;101:134\u201341. https:\/\/doi.org\/10.1111\/cge.14072.","journal-title":"Clin Genet"},{"key":"8_CR102","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/gim.2013.129","volume":"15","author":"ST South","year":"2013","unstructured":"South ST, Lee C, Lamb AN, Higgins AW, Kearney HM, Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013;15:901\u20139. https:\/\/doi.org\/10.1038\/gim.2013.129.","journal-title":"Genet Med"},{"key":"8_CR103","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1073\/pnas.1910456117","volume":"117","author":"R Garc\u00eda-Rodr\u00edguez","year":"2020","unstructured":"Garc\u00eda-Rodr\u00edguez R, Hiller M, Jim\u00e9nez-Gracia L, van der Pal Z, Balog J, Adamzek K, et al. Premature termination codons in the DMD gene cause reduced local mRNA synthesis. Proc Natl Acad Sci USA. 2020;117:16456\u201364. https:\/\/doi.org\/10.1073\/pnas.1910456117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR104","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1212\/WNL.0b013e318228c110","volume":"77","author":"M de Groot","year":"2011","unstructured":"de Groot M, Aronica E, Heimans JJ, Reijneveld JC. Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma. Neurology. 2011;77:532\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e318228c110.","journal-title":"Neurology"},{"key":"8_CR105","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.semcdb.2019.02.003","volume":"95","author":"K Ciruelas","year":"2019","unstructured":"Ciruelas K, Marcotulli D, Bajjalieh SM. Synaptic vesicle protein 2: a multi-faceted regulator of secretion. Semin Cell Dev Biol. 2019;95:130\u201341. https:\/\/doi.org\/10.1016\/j.semcdb.2019.02.003.","journal-title":"Semin Cell Dev Biol"},{"key":"8_CR106","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","volume":"38","author":"JG Mendoza-Torreblanca","year":"2013","unstructured":"Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farf\u00e1n BV, Carmona-Aparicio L, G\u00f3mez-Lira G. Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci. 2013;38:3529\u201339. https:\/\/doi.org\/10.1111\/ejn.12360.","journal-title":"Eur J Neurosci"},{"key":"8_CR107","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neubiorev.2016.03.022","volume":"65","author":"J Patak","year":"2016","unstructured":"Patak J, Zhang-James Y, Faraone SV. Endosomal system genetics and autism spectrum disorders: a literature review. Neurosci Biobehav Rev. 2016;65:95\u2013112. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.022.","journal-title":"Neurosci Biobehav Rev"},{"key":"8_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7100129","author":"Y Takarae","year":"2017","unstructured":"Takarae Y, Sweeney J. Neural hyperexcitability in autism spectrum disorders. Brain Sci. 2017. https:\/\/doi.org\/10.3390\/brainsci7100129.","journal-title":"Brain Sci"},{"key":"8_CR109","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajhg.2016.11.012","volume":"100","author":"FL Harms","year":"2017","unstructured":"Harms FL, Girisha KM, Hardigan AA, Kort\u00fcm F, Shukla A, Alawi M, et al. Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia, and facial dysmorphism. Am J Hum Genet. 2017;100:117\u201327. https:\/\/doi.org\/10.1016\/j.ajhg.2016.11.012.","journal-title":"Am J Hum Genet"},{"key":"8_CR110","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajhg.2016.11.018","volume":"100","author":"H-T Chao","year":"2017","unstructured":"Chao H-T, Davids M, Burke E, Pappas JG, Rosenfeld JA, McCarty AJ, et al. A syndromic neurodevelopmental disorder caused by de novo variants in EBF3. Am J Hum Genet. 2017;100:128\u201337. https:\/\/doi.org\/10.1016\/j.ajhg.2016.11.018.","journal-title":"Am J Hum Genet"},{"key":"8_CR111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fgene.2017.00143","volume":"8","author":"F Lopes","year":"2017","unstructured":"Lopes F, Soares G, Gon\u00e7alves-Rocha M, Pinto-Basto J, Maciel P. Whole gene deletion of EBF3 supporting haploinsufficiency of this gene as a mechanism of neurodevelopmental disease. Front Genet. 2017;8:143. https:\/\/doi.org\/10.3389\/fgene.2017.00143.","journal-title":"Front Genet"},{"key":"8_CR112","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajhg.2016.11.020","volume":"100","author":"H Sleven","year":"2017","unstructured":"Sleven H, Welsh SJ, Yu J, Churchill MEA, Wright CF, Henderson A, et al. De novo mutations in EBF3 cause a neurodevelopmental syndrome. Am J Hum Genet. 2017;100:138\u201350. https:\/\/doi.org\/10.1016\/j.ajhg.2016.11.020.","journal-title":"Am J Hum Genet"},{"key":"8_CR113","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a001743","volume":"3","author":"PR Blackburn","year":"2017","unstructured":"Blackburn PR, Barnett SS, Zimmermann MT, Cousin MA, Kaiwar C, Vairo EFP, et al. Novel de novo variant in EBF3 is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases. Mol Case Stud. 2017;3: a001743. https:\/\/doi.org\/10.1101\/mcs.a001743.","journal-title":"Mol Case Stud"},{"key":"8_CR114","volume-title":"GeneReviews\u00ae","author":"DL Narayanan","year":"1993","unstructured":"Narayanan DL, Kutsche K, Girisha KM, et al. EBF3 neurodevelopmental disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Mirzaa G, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 1993."},{"key":"8_CR115","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a002097","author":"AJ Tanaka","year":"2017","unstructured":"Tanaka AJ, Cho MT, Willaert R, Retterer K, Zarate YA, Bosanko K, et al. De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism. Cold Spring Harb Mol Case Stud. 2017. https:\/\/doi.org\/10.1101\/mcs.a002097.","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"8_CR116","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40246-021-00342-3","volume":"15","author":"EM Padhi","year":"2021","unstructured":"Padhi EM, Hayeck TJ, Cheng Z, Chatterjee S, Mannion BJ, Byrska-Bishop M, et al. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism. Hum Genomics. 2021;15:44. https:\/\/doi.org\/10.1186\/s40246-021-00342-3.","journal-title":"Hum Genomics"},{"key":"8_CR117","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000513583","volume":"12","author":"M Jim\u00e9nez de la Pe\u00f1a","year":"2021","unstructured":"Jim\u00e9nez de la Pe\u00f1a M, Jim\u00e9nez de Domingo A, Tirado P, Calleja-P\u00e9rez B, Alcaraz LA, \u00c1lvarez S, et al. Neuroimaging findings in patients with EBF3 mutations: report of two cases. Mol Syndromol. 2021;12:186\u201393. https:\/\/doi.org\/10.1159\/000513583.","journal-title":"Mol Syndromol"},{"key":"8_CR118","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/pd.5369","volume":"38","author":"S Zampatti","year":"2018","unstructured":"Zampatti S, Mela J, Peconi C, Pagliaroli G, Carboni S, Barrano G, et al. Identification of Duchenne\/Becker muscular dystrophy mosaic carriers through a combined DNA\/RNA analysis. Prenat Diagn. 2018;38:1096\u2013102. https:\/\/doi.org\/10.1002\/pd.5369.","journal-title":"Prenat Diagn"},{"key":"8_CR119","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"key":"8_CR120","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1172-7-45","volume":"7","author":"A Nicolas","year":"2012","unstructured":"Nicolas A, Lucchetti-Miganeh C, Yaou RB, Kaplan J-C, Chelly J, Leturcq F, et al. Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database. Orphanet J Rare Dis. 2012;7:45. https:\/\/doi.org\/10.1186\/1750-1172-7-45.","journal-title":"Orphanet J Rare Dis"},{"key":"8_CR121","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IFAC Fokkema","year":"2011","unstructured":"Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT. LOVD vol 2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557\u201363. https:\/\/doi.org\/10.1002\/humu.21438.","journal-title":"Hum Mutat"},{"issue":"7","key":"8_CR122","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/jhg.2016.28","volume":"61","author":"A Nakamura","year":"2016","unstructured":"Nakamura A, Fueki N, Shiba N, Motoki H, Miyazaki D, Nishizawa H, Echigoya Y, Yokota T, Aoki Y, Takeda S. Deletion of exons 3\u20139 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy. J Hum Genet. 2016;61(7):663\u20137. https:\/\/doi.org\/10.1038\/jhg.2016.28.","journal-title":"J Hum Genet"},{"issue":"11","key":"8_CR123","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.nmd.2014.06.003","volume":"24","author":"M Zatz","year":"2014","unstructured":"Zatz M, Pavanello RC, Lazar M, Yamamoto GL, Louren\u00e7o NC, Cerqueira A, Nogueira L, Vainzof M. Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin. Neuromuscul Disord. 2014;24(11):986\u20139. https:\/\/doi.org\/10.1016\/j.nmd.2014.06.003.","journal-title":"Neuromuscul Disord"},{"key":"8_CR124","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ejhg.2013.169","volume":"22","author":"APM de Brouwer","year":"2014","unstructured":"de Brouwer APM, Nabuurs SB, Verhaart IEC, Oudakker AR, Hordijk R, Yntema HG, et al. A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy. Eur J Hum Genet. 2014;22:480\u20135. https:\/\/doi.org\/10.1038\/ejhg.2013.169.","journal-title":"Eur J Hum Genet"},{"key":"8_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111635","author":"MS Nadeem","year":"2021","unstructured":"Nadeem MS, Hosawi S, Alshehri S, Ghoneim MM, Imam SS, Murtaza BN, et al. Symptomatic Genetic, and Mechanistic Overlaps between Autism and Alzheimer\u2019s Disease. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11111635.","journal-title":"Biomolecules"},{"key":"8_CR126","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/aur.2590","volume":"14","author":"G Vivanti","year":"2021","unstructured":"Vivanti G, Tao S, Lyall K, Robins DL, Shea LL. The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder. Autism Res. 2021;14:2189\u201399. https:\/\/doi.org\/10.1002\/aur.2590.","journal-title":"Autism Res"},{"key":"8_CR127","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11689-011-9076-5","volume":"3","author":"AT Pagnamenta","year":"2011","unstructured":"Pagnamenta AT, Holt R, Yusuf M, Pinto D, Wing K, Betancur C, et al. A family with autism and rare copy number variants disrupting the Duchenne\/Becker muscular dystrophy gene DMD and TRPM3. J Neurodev Disord. 2011;3:124\u201331. https:\/\/doi.org\/10.1007\/s11689-011-9076-5.","journal-title":"J Neurodev Disord"},{"key":"8_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.635659","volume":"9","author":"K Held","year":"2021","unstructured":"Held K, T\u00f3th BI. TRPM3 in brain (patho)physiology. Front Cell Dev Biol. 2021;9: 635659. https:\/\/doi.org\/10.3389\/fcell.2021.635659.","journal-title":"Front Cell Dev Biol"},{"key":"8_CR129","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neuron.2015.09.048","volume":"88","author":"E Karaca","year":"2015","unstructured":"Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, et al. Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron. 2015;88:499\u2013513. https:\/\/doi.org\/10.1016\/j.neuron.2015.09.048.","journal-title":"Neuron"},{"key":"8_CR130","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41436-019-0610-2","volume":"22","author":"Y Du","year":"2020","unstructured":"Du Y, Li Z, Liu Z, Zhang N, Wang R, Li F, et al. Nonrandom occurrence of multiple de novo coding variants in a proband indicates the existence of an oligogenic model in autism. Genet Med. 2020;22:170\u201380. https:\/\/doi.org\/10.1038\/s41436-019-0610-2.","journal-title":"Genet Med"},{"key":"8_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23584","author":"SM Sanchez-Sanchez","year":"2018","unstructured":"Sanchez-Sanchez SM, Magdalon J, Griesi-Oliveira K, Yamamoto GL, Santacruz-Perez C, Fogo M, et al. Rare RELN variants affect Reelin-DAB1 signal transduction in autism spectrum disorder. Hum Mutat. 2018. https:\/\/doi.org\/10.1002\/humu.23584.","journal-title":"Hum Mutat"},{"key":"8_CR132","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1038\/s41436-019-0477-2","volume":"21","author":"ED Smith","year":"2019","unstructured":"Smith ED, Blanco K, Sajan SA, Hunter JM, Shinde DN, Wayburn B, et al. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses. Genet Med. 2019;21:2199\u2013207. https:\/\/doi.org\/10.1038\/s41436-019-0477-2.","journal-title":"Genet Med"},{"key":"8_CR133","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cge.12987","volume":"92","author":"TB Balci","year":"2017","unstructured":"Balci TB, Hartley T, Xi Y, Dyment DA, Beaulieu CL, Bernier FP, et al. Debunking Occam\u2019s razor: diagnosing multiple genetic diseases in families by whole-exome sequencing. Clin Genet. 2017;92:281\u20139. https:\/\/doi.org\/10.1111\/cge.12987.","journal-title":"Clin Genet"},{"key":"8_CR134","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41582-021-00564-y","volume":"17","author":"I Fyfe","year":"2021","unstructured":"Fyfe I. Early-onset dementia in autism spectrum disorder. Nat Rev Neurol. 2021;17:595. https:\/\/doi.org\/10.1038\/s41582-021-00564-y.","journal-title":"Nat Rev Neurol"}],"container-title":["Discover Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-022-00008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44192-022-00008-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-022-00008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T01:09:15Z","timestamp":1648084155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44192-022-00008-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s44192-022-00008-z","relation":{},"ISSN":["2731-4383"],"issn-type":[{"value":"2731-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the ethics committee of the Brazilian National Research Ethics Commission CAAE43559314.0.0000.5464. All participants or their legal guardians provided written consent to participate. All family members (or their legal guardians) described in this article provided written consent to publish the collected information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}